SIGA Technologies, Inc. (SIGA) 是一家上市公司 属于 医疗保健 板块，经营于 制药 - 专科与仿制药 行业. 公司总部位于 New York City, NY, 美国. 现任CEO为 Diem Nguyen.
SIGA 拥有 IPO日期为 1997-09-10, 46 名全职员工, 在 NASDAQ Global Market, 市值为 $336.73M.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
